Merck & Co Inc
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% […]
Read More
Stocks making the biggest moves premarket: Walmart, Target, Apple, Pfizer, Eli Lilly, Ford and more
Check out the companies making headlines before the bell. Pharmaceutical stocks – Shares of U.S. companies in the pharmaceutical industry fell after President Donald Trump said late Tuesday that he’s going to announce ” very shortly a major tariff on pharmaceuticals .” Pfizer and Merck shares each dropped more than 4%, while Eli Lilly shed […]
Read More
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Signage at the AstraZeneca facility in Gaithersburg, Maryland, US, on Monday, Aug. 26, 2024. Graeme Sloan | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The race to develop more convenient […]
Read More
Family office dealmaking doubled in February with bets on crab shells, nuclear reactors and more
A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high net worth investor and consumer. Sign up to receive future editions, straight to your inbox. Last month, family offices made at least 48 direct investments, double that of the month prior, according to data […]
Read More
European markets fall as traders digest latest Trump tariff reprieve; Luxury stocks decline
European markets were broadly lower Friday, rounding off a volatile week marked by whipsawing policy on U.S. tariffs, the latest rate cut from the European Central Bank, German fiscal reforms and a regional defense spending boost. The regional Stoxx 600 index was down 0.65% at 10:20 a.m. U.K. time, with retail and household goods stocks […]
Read More
Air France-KLM pops 16% after profit beat; Europe markets open higher ahead of ECB meeting
European markets opened higher on Thursday as investors look ahead to the latest monetary policy decision of the European Central Bank. Source
Read More
U.S. investors, Big Pharma race to find new medicines in China
A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. \ Nurphoto | Nurphoto | Getty Images A little-known biotech company stunned the biopharmaceutical industry last spring when it declared an “unprecedented” achievement: its experimental cancer drug looked more effective than […]
Read More
Trump is unlikely to end Medicare drug price talks — here’s what that means for patients and pharma
President Donald Trump arrives in the Brady Press Briefing Room at the White House on Jan. 30, 2025 in Washington, DC. Oliver Contreras | Afp | Getty Images President Donald Trump likely won’t do away with a landmark process that allows Medicare to negotiate drug prices with manufacturers, even as he moves to erase Joe […]
Read More
Bristol Myers’ stock decline in response to weak guidance is a gift to investors
Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares lower. Jim Cramer’s faith in the drugmaker is unshaken. Revenue in the fourth quarter rose 8% year over year to $12.34 billion, well ahead of the $11.57 billion consensus, according to analysts’ estimates compiled by LSEG. Adjusted earnings per […]
Read More